Rheumatoid Arthritis–Associated Interstitial Lung Disease: Risks, Recognition, and Collaborative Management Strategies
Learning objectives:
Identify key risk factors, clinical manifestations, and the overall disease burden of rheumatoid arthritis–associated interstitial lung disease (RA-ILD), with an emphasis on early recognition and appropriate screening strategies.
Apply evidence-based diagnostic and therapeutic approaches for RA-ILD, including the interpretation of imaging, pulmonary function tests, and the selection of appropriate treatment options.
Collaborate effectively with respirologists to design and implement comprehensive, interdisciplinary care plans that address the complex needs of patients living with RA-ILD.
Program date: September 18, 2025
Speaker: Dr. Caylib Durand, PhD, MD, FRCPC
Clinical Rheumatologist
Peak Medical Specialty Center
Calgary, Alberta, Canada
Speaker: Dr. Ciaran Scallan, MD, FRCPC
Assistant Professor – University of Toronto
Respirology and Lung Transplant
Ajmera Transplant Center | University Health Network
Moderator: Dr. Janet Pope, MD, MPH, FRCPC
Rheumatologist
Professor of Medicine and
Member of the Division of
Rheumatology
Western University
Schulich School of Medicine
London, Ontario
Questions?
The presenters are solely responsible for developing the content of this presentation and maintaining scientific accuracy, objectivity, and balance. Any discussions of clinical practice or treatment represent the opinions of the presenter alone. This video is made available for attendees, registrants, and individuals requesting further information on this learning program.